The Doherty Institute's Sharon Lewin (Graham Hughes/The Canadian Press via AP Images)

From Aus­tralia, new $173M re­search cen­ter strives to be at the fore­front of pan­dem­ic drug dis­cov­ery

In the bat­tle against Covid-19, vac­cines came much ear­li­er than ther­a­peu­tics. A new re­search in­sti­tu­tion in Mel­bourne wants to change that.

Ge­of­frey Cum­ming, a Cana­di­an-born oil and gas busi­ness­man, do­nat­ed AUD $250 mil­lion ($173.63 mil­lion) to es­tab­lish the Cum­ming Glob­al Cen­tre for Pan­dem­ic Ther­a­peu­tics — whose man­date is to fund “an am­bi­tious re­search pro­gram fo­cus­ing on treat­ments that can be rapid­ly adapt­ed af­ter a new virus is iden­ti­fied.”

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.